Effects of manidipine and nitrendipine enantiomers on the plateau phase of K+-induced intracellular Ca2+ increase in GH3 cells

European Journal of Pharmacology

Volumn 376, Issue 1-2, 1999, Pages 169-178

  Cataldi, Mauro ^a   Taglialatela, Maurizio ^a   Palagiano, Francesco ^a   Secondo, Agnese ^a   De Caprariis, Paolo ^b   Amoroso, Salvatore ^a   Di Renzo, Gianfranco ^c   Annunziato, Lucio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Ca2+ channel, voltage sensitive; Ca2+ concentration, intracellular; Chirality; Dihydropyridine; Manidipine; Nitrendipine

Indexed keywords

CALCIUM CHANNEL; DIHYDROPYRIDINE DERIVATIVE; MANIDIPINE; NITRENDIPINE;

ARTICLE; CALCIUM TRANSPORT; CELL STRAIN GH3; CHIRALITY; CONTROLLED STUDY; ENANTIOMER; HUMAN; HUMAN CELL; MICROFLUOROMETRY; PATCH CLAMP; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELL LINE; DIHYDROPYRIDINES; FLUORESCENT DYES; FLUOROMETRY; FURA-2; INTRACELLULAR FLUID; NITRENDIPINE; PATCH-CLAMP TECHNIQUES; POTASSIUM; RATS; STEREOISOMERISM;

EID: 0032990812     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00149-1     Document Type: Article

References (24)

1. Bossert F., Horstmann H., Meyer H., Vater W. Einfluβ der ester-funktion auf die vasodilatierenden eigenschaften von 1,4-dihydro-2,6-dimethyl-4-nitrophenyl-pyridin-3,5-dicarbonsäureestern. Arzneim. Forsch. Drug Res. 29:1979;226-229.
2. 3 cells. J. Biol. Chem. 271:1996;9441-9446.
3. Delee E., Jullien I., Le Garrec L. Direct high-performance liquid chromatographic resolution of dihydropyridine enantiomers. J. Chromatogr. 450:1988;191-197.
4. Eltze M., Boer R., Sanders K.H., Boss H., Ulrich W.-R., Flockerzi D. Stereoselective inhibition of thromboxane-induced coronary vasoconstriction by 1,4-dihydropyridine calcium channel antagonists. Chirality. 2:1990;233-240.
5. +-induced cytosolic changes in rat cortical synaptosomes. J. Neurochem. 53:1989;392-398.
6. Goa K.L., Sorkin E.M. Nitrendipine: a review of its pharmacodynamic and pharmacokinetic properties, and its efficacy in the treatment of hypertension. Drugs. 33:1987;123-155.
7. Goldmann S., Stoltefuss J. 1,4-Dihydropyridines: effect of chirality and conformation on the calcium antagonist and calcium agonist activities. Angew. Chem. Int. Ed. Engl. 30:1991;1559-1578.
8. Hamill O.P., Marty E., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membranae patches. Pflüg. Arch. 391:1981;85-100.
9. Hockermann G.H., Peterson B.Z., Johnson B.D., Catteral W.A. Molecular determinants of drug binding and action on L-type calcium channels. Annu. Rev. Pharmacol. Toxicol. 37:1997;61-96.
10. Kajino M., Wada Y., Nagai Y., Nagaoka A., Meguro K. Synthesis and biological activities of optical isomers of 2-(-4-diphenylmethyl-1-piperazinyl)ethyl-methyl 1,4-dihydro-2,6-dimethyl-4-(-3-nitrophenyl)-3-5-pyridinedicarboxylate (Manidipine) dihydrochloride. Chem. Pharm. Bull. 37:1989;2225-2228.
11. Keller E., Nussinovitch I. Activity-dependent ultra-slow inactivation of calcium currents in rat anterior pituitary cells. J. Neurophysiol. 76:1996;2157-2168.
12. Kojda G., Klaus W., Werner G., Frike U. The influence of 3-ester side chain variation on the cardiovascular profile of nitrendipine in porcine isolated trabeculae and coronary arteries. Naunyn-Schmiedegerg's Arch. Pharmacol. 344:1991;488-494.
13. Lee K.S., Tsien R.W. Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature. 302:1983;790-794.
14. Meguro K., Aizawa M., Sohda T., Kawamatsu Y., Nagaoka A. New 1,4-dihydropyridine derivatives with potent and long-lasting hypotensive effects. Chem. Pharm. Bull. 33:1985;3789-3797.
15. Mikus G., Mast V., Ratge D., Wisser H., Eichelbaum M. Stereoselectivity in cardiovascular and biochemical action of calcium antagonist: studies with the enantiomers of the dihydropyridine nitrendipine. Clin. Pharmacol. Ther. 57:1995;52-61.
16. Morimoto S., Hisaki K., Matsamura Y. Effects of manidipine hydrochloride, nisoldipine and nitrendipine on renal hemodynamics and function in stroke-prone spontaneously hypertensive rats (SHRSP). Jpn. Pharmacol. Ther. 18:1990;2889-2898.
17. Okabe K., Terada K., Kitamura K., Kuriyama H. Selective and long-lasting inhibitory actions of the dihydropyridine derivative, CV-4093, on calcium currents in smooth muscle cells of the rabbit pulmonary artery. J. Pharmacol. Exp. Ther. 243:1987;703-710.
18. Okamoto Y.R., Aburatani K., Hatada M., Honda N., Inotsume, Nakano M. Optical resolution of dihidropyridine enantiomers by high performance liquid chromatography using phenylcarbamates of polysaccharides as chiral stationary phase. J. Chromatogr. 513:1990;375-378.
19. Ozawa S., Kimura N. Calcium channel and prolactin release in rat clonal pituitary cells: effect of verapamil. Am. J. Physiol. 243:1982;E68-E73.
20. 3 pituitary cells. Proc. R. Soc. London B Biol. Sci. 245:1991;127-131.
21. Stalcup A.M., Chang S.C., Armstrong D.W., Pitha J. (S)-2-Hydroxypropyl-b-cyclodextrin a new chiral stationary phase for reversed-phase liquid chromatography. J. Chromatogr. 513:1990;181-194.
22. Tokuma Y.T., Fujiwara, Noguchi H. Determination of (+)- and (-)-nilvadipine in human plasma using chiral stationary-phase liquid chromatography and gas chromatography-mass spectrometry and a preliminary pharmacokinetic study in humans. J. Pharm. Sci. 76:1987;310-313.
23. Triggle D.J., Janis R.A. Calcium channels ligands. Annu. Rev. Pharmacol. Toxicol. 27:1987;347-369.
24. Van Zwieten P.A., Pfaffendorf M. Similarities and differences between calcium antagonists: pharmacological aspects. J. Hypertens. 11:1993;S3-S11.